Skip to main content
. 2022 Aug 30;18:889–900. doi: 10.2147/TCRM.S375067

Table 1.

Basic Information of GLP-1RAs

Common Name Approved Regions (Time)
Exenatide Injection, China (2009), Europe (2010), United States (2005), Japan (2010)
Liraglutide Injection China (2011), Europe (2009), United States (2010), Japan (2010)
Lixisenatide Injection China (2018), Europe (2013), United States (2016), Japan (2013)
Benaglutide Injection China (2016)
Dulaglutide Injection China (2019), Europe (2014), United States (2014), Japan (2015)
Polyethylene Glycol Loxenatide Injection China (2019)
Semaglutide Injection China (2021), Europe (2018), United States (2017), Japan (2018)